Hospital Day : 9

ID & Chief Concern / Problem ( required for all billing levels )
62 F ( depression , HL ) with new diagnosis of AML ( FLT3 , NPM1 , CEBP negative ) here for scheduled admit for induction GCLAC therapy plus expanded umbilical cord cells SCCA protocol 2335 .

Interval History / Major Events ( past 24 hours )
- patient persistently febrile overnight to 38.7
- this morning , reports that she 's not feeling so good : headache consistent with chemo headache , nausea and vomiting , diarrhea x 2 BM yesterday , abdominal cramping somewhat relieved by BM
- denies cough / difficulty breathing
- reports that rash is somewhat itchy , unsure whether it has changed or not .
- nasal swab sent for panel after sinus congestion at shift change
- received 1 U PRBC , platelet transfusion
- this morning , patient found to be slightly more groggy than usual , VSS , non focal exam , sent for head CT

Allergies
cephalexin
Zofran
Latex
Shrimp

Scheduled Medications
Acyclovir 800 mg tab Dose : 800 mg = 1 tab PO Q12 Hours
Aminocaproic acid Dose : 2 g = 8 mL IVPB Q6 Hours
cefTAZidime Dose : 2 g IVPB Q8 Hours
Chlorhexidine gluconate 2 % topical cloth Dose : 1 application Topical QAM
Filgrastim 300 mcg/mL inj Dose : 300 mcg = 1 mL Subcutaneous Q24 Hours
Lorazepam 0 . 5mg tab Dose : 1 mg = 2 tab PO Q6 Hours
Prochlorperazine 10 mg tab Dose : 10 mg = 1 tab PO Q8 Hours
Ranitidine 150 mg tab Dose : 150 mg = 1 tab PO Q12 Hours
Scopolamine 1 . 5mg patch Dose : 1.5 mg = 1 patch Transdermal Q72 Hours
Sertraline 25 mg tab Dose : 50 mg = 2 tab PO QDay

Infusions
Sodium Chloride 0.9 % 1 , 000 mL Dose : 1 , 000 mL IV Infusion

PRN Medications
Acetaminophen 325 mg tab Dose : 325-650 mg PO Q6 Hours PRN
Bisacodyl EC 5 mg tab Dose : 30 mg = 6 tab PO QDay PRN
Calcium carb 500 mg chewtab ( 200 mg elem ) Dose : 500-1000 mg Chew Q6 Hours PRN
DiphenhydrAMINE 25 mg tab Dose : 25-5 0 mg PO Q6 Hours PRN
DiphenhydrAMINE 50 mg/mL inj Dose : 25-5 0 mg IV Q6 Hours PRN
Docusate 100 mg cap Dose : 200 mg = 2 cap PO BID PRN
Granisetron 1 mg tab Dose : 1 mg = 1 tab PO BID PRN
Lactulose 20g / 30mL soln Dose : 15-30 mL PO Q4 Hours PRN
Loperamide 2 mg cap Dose : 2 mg = 1 cap PO Q3 Hours PRN
Lorazepam 0 . 5mg tab Dose : 0.5-1 mg PO Q6 Hours PRN
Lorazepam 2 mg/mL inj Dose : 0.5-1 mg IV Push Q6 Hours PRN
Metoclopramide 10mg / 2mL inj Dose : 10 mg = 2 mL IV Q6 Hours PRN
Oxycodone 5 mg tab Dose : 5-15 mg PO Q4 Hours PRN
Polyethylene glycol 3350 - NF powder 17 g Dose : 17 g = 1 packet PO QDay PRN
Prochlorperazine 5 mg tab Dose : 5-10 mg PO Q6 Hours PRN
Senna 8 . 6mg tab Dose : 1 tab PO QHS PRN

Vitals ( Most recent and 24 hour range . )
Date
Result
Last
MIN
- MAX
01/21/12 04:45
Temp C :
38.7
36.0
- 38.7
01/21/12 06:14
HR :
100
76
- 100
01/21/12 04:45
RR :
18
14
- 20
01/21/12 06:14
SBP Non - Inv :
126
98
- 126
01/21/12 06:14
DBP Non - Inv :
68
58
- 68

I & O Data
Height : 162 ( cm ) 5 ' 4 " ( ft / in ) ( 01/14/2012 )
Admit Wt : 61.4 ( kg ) 135 ( lbs ) ( 01/14/2012 )
Last Daily Wt : 62.9 ( kg ) 138 ( lbs ) ( 01/20/12 13:00 )
Previous Daily Wt : 62.7 ( kg ) 138 ( lbs ) ( 01/18/12 08:00 )

( 24 Hour IO Total = from 06:00 the prior day to 05:59 listed day )
Result
01/18/2012
01/19/2012
01/20/2012
01/21/2012
01/22/2012
Total

Intake Total ( 0600 )
2907
1100
820
4604
308
9739

Output Total ( 0600 )
2600
2900
2700
2100
0
10300

Net I & O Total ( 0600 )
307
- 1800
- 1880
2504
308
- 561

Daily weight
63
62.7

62.9

N / A


Respiratory Data ( Most recent and 24 hour range . )
Date
01/20/12 16:00
O2 Sat :
98
O2 Delivery Device :
Room air

Physical Exam ( include 8 or 2 with one in detail )
CONSTITUTIONAL / GENERAL APPEARANCE : NAD , slightly groggy
MENTAL STATUS / PSYCH : month " november ? march ? february ? " year " 2012 " place " UW "
NEURO : nonfocal , PERRL , EOMI , extremities moving spontaneously , strength symmetric
EARS , NOSE , THROAT : palatal petechiae
RESPIRATORY : CTAB
CARDIOVASCULAR ( heart , pulses , edema ) : RRR
ABDOMEN / GI : NTND
SKIN : diffuse blanching maculopapular erythematous rash on trunk , back , legs , and feet

Laboratory Studies ( Most recent results in 24 hour range . )

RESULTS FROM TODAY
RESULTS FROM YESTERDAY

01/21/12 00:30
01/20/12 18:55


| - ICa - - -
| - ICa - - -
129
101
15
| - Ca 7.1

131
101
12
| - Ca 7.5
- - - - - - - - - | - - - - - - - - - - - - - | - - - - - - - - - - - - < 124
| - Mg - - -

- - - - - - - - - | - - - - - - - - - - - - - | - - - - - - - - - - - - < 116
| - Mg 1.9
3.5
24
0.67
| - Phos - - -

3.7
24
0.55
| - Phos 3.0


RESULTS FROM TODAY
RESULTS FROM YESTERDAY

01/21/12 00:30
01/20/12 00:30


8.0
| - PT - - -
9.7
| - PT - - -
cmt ] - - - - - - - - - - - - - - - - - - - - - - [ 4
| - INR - - -
cmt ] - - - - - - - - - - - - - - - - - - - - - - [ 10
| - INR - - -

23
| - PTT - - -
29
| - PTT - - -

Other Laboratory Studies ( Most recent and 24 hour range . )
Date
01/21/12 00:30
AST ( GOT ) :
52
ALT ( GPT ) :
164
Alk Phos ( Total ) :
119
Bilirubin ( Total ) :
0.6
Albumin :
2.3

Last 6 Hematocrits in Preceding 24 Hours
( NOTE : Comments / notes for Labs are viewable on Flowsheet )
01/21/12
01/20/12

00:30
00:30

23
29

Imaging
CT Head 1/21/12
Preliminary Impression :
1 . No acute intracranial abnormality . Specifically there is no acute
infarct , hemorrhage , mass or edema .

Problems / Assessment / Plan
62 F with h/o depression , HLD and recent diagnosis of AML ( FLT3 , NPM1 , CEBP negative ) admitted for induction GCLAC therapy plus expanded umbilical cord cells SCCA protocol 2335 , now with neutropenic fever

# ) Neutropenic fever , rash , AMS : only localizing symptom is abdominial discomfort , which has been present for several days , correlated with chemo . Patient initially received one dose of meropenem , then ceftazidime , now on vanc / aztreonam given rash and possibility of cephalosporin allergic crossreactivity . Possibly related to umbilical cord cell infusion . VSS. CT Head negative
[ ] monitor BCx and further sx .
[ ] will discuss possibility of acute GVHD

# ) AML ( FLT3 , NPM1 , CEBP negative ) : patient here for induction GCLAC therapy . NOW DAY 7 / 5 . patient now with an undetectable white count , stable Hct and decreasing platelets . Completed GCLAC therapy ( filgrastim , cytarabine , clofarabine ) and umbilical cord cells transfusion . Now eligible for discharge per protocol but not feeling well and logistical issues are not yet figured out . Patient will ultimately need a bone marrow biopsy on Day 14 , which is 1/25/12 . At that time , she will require morphology , flow , and cyto / FISH if clinically indicated .
[ ] transfusion threshold : Hct < 26 , plt < 10

[ ] continue filgrastim 300 mcg subcutaneous injection qday until ANC > 2000 for 2 days
[ ] continue neutropenia prophylaxis antibiotics today , including :

acyclovir 800 mg PO bid

hold fluconazole ppx for now given transaminitis ; plan to start in next 1-2 days

# ) Nausea and diarrhea : symptoms persistent today , likely still related to chemo . Also with discomfort c / t reflux
- ctn Tums , started ranitidine yesterday
- Scheduled compazine and ativan ,
- c diff negative loperamide ok if negative

# ) transaminitis : unclear etiology , likely 2 / 2 chemotherapy toxicities . resolving .
[ ] holding hepatotoxic drugs

# ) Other issues stable and unchanged :
- HL : holding simvastatin 10 mg PO qhs given transaminitis
- depression : continue sertraline 50 mg PO qday

# ) FEN : regular diet , replete lytes PRN , continue bowel regimen including docusate , senna , and miralax PRN .
# ) PPX : TEDs / SCDs , GI deferred at this time
# ) T / L / D : Hickman line placed 1/12/2012
# ) Contacts : Husband ( 253 ) 759-3251
# ) Code : FULL
# ) Dispo : discharge delayed for fever








ATTENDING STATEMENT :
I saw and evaluated the patient and agree with Dr. Chen 's note . Persistently febrile . Very acute development of diffuse erythematous rash , initially mostly affecting trunk and flank but later extending to face and other body areas ; with progression development of pain in erythematous areas . Hyperacute GVHD unlikely as expanded CB cells should not contain any mature T lymphocytes . Possible allergic reaction to medication or beginning cytarabine toxicity ; in favor of the latter is the worsening pain associated with the rash . Will obtain CT scan because of altered mental status in setting of severe thrombocytopenia and consider diagnostic LP at later time point . Will give systemic steroids if allowed by study protocol .

Date of Service : 01/21/2012

Today 's Date is : 01/21/2012